[RNAZ] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
01-Apr-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 47.21%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 -
PBT -18,546 -17,565 -6,843 -2,344 -607 -453 110.01%
Tax 0 17,565 95 394 157 -69 -
NP -18,546 -35,130 -6,938 -2,738 -764 -453 110.01%
Tax Rate - - - - - - -
Total Cost 18,546 35,130 6,938 2,738 764 453 110.01%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -103.61 -2,195.62 -658.80 -343.19 -119.27 -70.77 7.91%
EPS Diluted -103.61 -2,165.57 -658.80 -343.19 -119.27 -70.77 7.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.